Compound Detail
CHEMBL1555
GALANTAMINE HYDROBROMIDE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
6
Targets
32
Activities
3
Assay Types
23
PK Parameters
20
Publications
10
Known Names
8
Indications
1
Mechanisms
Molecular Properties
287.4
MW (Da)
1.85
ALogP
4
HBA
1
HBD
41.9
PSA (Ų)
0.80
QED
0
Ro5 Violations
1
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2001 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Acetylcholinesterase inhibitor | INHIBITOR | Acetylcholinesterase | ✓ | ✓ |
Indications
Alzheimer Disease Dementia Brain Diseases Cognitive Dysfunction Dementia, Vascular Mental Disorders Schizophrenia Frontotemporal Dementia
Activity Summary
IC50 18 meas. best 6.66
Ki 13 meas. best 6.43
EC50 1 meas. best 4.96
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Acetylcholinesterase CHEMBL4078 | IC50 | 6.66 | 6.0583 | 220.0 | 6 |
| Acetylcholinesterase CHEMBL4078 | Ki | 6.43 | 6.3289 | 370.0 | 9 |
| Acetylcholinesterase CHEMBL4780 | IC50 | 5.97 | 5.97 | 1069.0 | 2 |
| Cholinesterase CHEMBL5763 | IC50 | 5.82 | 5.035 | 1520.0 | 6 |
| Cholinesterase CHEMBL5763 | Ki | 5.68 | 5.2775 | 2070.0 | 4 |
| Acetylcholinesterase CHEMBL220 | IC50 | 5.58 | 5.5 | 2600.0 | 3 |
| Unchecked CHEMBL612545 | EC50 | 4.96 | 4.96 | 11054.0 | 1 |
| Butyrylcholinesterase CHEMBL5077 | IC50 | 4.9 | 4.9 | 12600.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 991.39 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 830.47 | ng.hr.mL-1 | Rattus norvegicus |
| CL | 5.667 | mL.min-1.kg-1 | Homo sapiens |
| CL | 34.0 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 41.0 | mL.min-1.kg-1 | Rattus norvegicus |
| Cmax | 1330.0 | nM | Rattus norvegicus |
| Cmax | 910.0 | nM | Rattus norvegicus |
| Cmax | 890.0 | nM | Rattus norvegicus |
| Cmax | 590.0 | nM | Rattus norvegicus |
| F | 85.0 | % | Homo sapiens |
| F | 67.0 | % | Rattus norvegicus |
| F | 83.0 | % | Rattus norvegicus |
| MRT | 1.5 | hr | Rattus norvegicus |
| MRT | 2.0 | hr | Rattus norvegicus |
| T1/2 | 5.0 | hr | Homo sapiens |
| T1/2 | 1.2 | hr | Rattus norvegicus |
| T1/2 | 1.9 | hr | Rattus norvegicus |
| Tmax | 1.0 | hr | Homo sapiens |
| Tmax | 0.5 | hr | Rattus norvegicus |
| Tmax | 0.5 | hr | Rattus norvegicus |
| Vd | 2.9 | L.kg-1 | Homo sapiens |
| Vd | 2.9 | L.kg-1 | Rattus norvegicus |
| Vd | 5.0 | L.kg-1 | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine